Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Muller S, Schütt P, Bojko P, Nowrousian MR, Hense J, Seeber S, Moritz T. Ann. Hematol. 2005 Feb; 84(2):110-4

Ann Hematol. 2005 Sep;84(9):621-2. doi: 10.1007/s00277-005-1049-x. Epub 2005 May 14.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Fatal Outcome
  • Gemcitabine
  • Hemolytic-Uremic Syndrome / chemically induced*
  • Humans
  • Kidney Neoplasms / complications
  • Kidney Neoplasms / drug therapy
  • Male
  • Multiple Organ Failure

Substances

  • Deoxycytidine
  • Gemcitabine